A. Rauf et al. / Journal of Molecular Structure 1198 (2019) 126866
7
B.S. Dawane, Synthesis and in silico investigation of thiazoles bearing pyr-
azoles derivatives as anti-inflammatory agents, Comput. Biol. Chem. 61 (2016)
[6] E. Bellale, M. Naik, V.B. Varun, A. Ambady, A. Narayan, S. Ravishankar,
V. Ramachandran, P. Kaur, R. McLaughlin, J. Whiteaker, et al., Diarylthiazole:
an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component
[7] M.R. Shiradkar, K.C. Akula, V. Dasari, V. Baru, B. Chiningiri, S. Gandhi, R. Kaur,
A novel approach to cyclin dependent kinase 5/p25 inhibitors as a potential
treatment for Alzheimer's disease, Bioorg. Med. Chem. 15 (2007) 2601e2610,
[8] S.Y. Kang, K.S. Song, J. Lee, S.H. Lee, J. Lee, Synthesis of pyridazine and thiazole
analogues as SGLT2 inhibitors, Bioorg. Med. Chem. 18 (2010) 6069e6079,
[9] D.S. Prasanna, C.V. Kavitha, K. Vinaya, S.R. Ranganatha, S.C. Raghavan,
K.S. Rangappa, Synthesis and identification of a new class of anti-leukemic
agents containing 2-(arylcarboxamide)-(S)-6-amino-4,5,6,7-tetra hydro-
[27] S.O. Pember, G.L. ejia, T.J. Price, R.J. Pasteris, Piperidinyl thiazole isoxazolines:
a new series of highly potent, slowly reversible FAAH inhibitors with anal-
gesic properties, Bioorg. Med. Chem. Lett. 26 (2016) 2965e2973, https://
[28] M.F. Arshad, N. Siddiqui, A. Elkerdasy, A.H. Al Rohaimi, S.A. Khan, Anticon-
vulsant and neurotoxicity evaluation of some newly synthesized thiazolyl
coumarin derivatives, Am. J. Pharmacol. Toxicol. 9 (2014) 132e138, https://
[29] C.B. Mishra, S. Kumari, M. Tiwari, Thiazole: a promising heterocycle for the
development of potent CNS active agents, Eur. J. Med. Chem. 92 (2015) 1e34,
[30] F. Chimenti, B. Bizzarri, E. Maccioni, D. Secci, A. Bolasco, P. Chimenti,
R. Fioravanti, A. Granese, S. Carradori, F. Tosi, P. Ballario, S. Vernarecci,
P. Filetici,
network:
A
novel histone acetyltransferase inhibitor modulating Gcn5
cyclopentylidene-[4-(4'-chlorophenyl) thiazol-2-yl)hydrazine,
[10] S.K. Bharti, K. Nath, R. Tilak, S.K. Singh, Synthesis, anti-bacterial and anti-
fungal activities of some novel Schiff bases containing 2, 4-disubstituted
[11] O.I. El-Sabbagh, M.M. Baraka, S.M. Ibrahim, C. Pannecouque, R. Snoeck,
J. Balzarini, A.A. Rashad, Synthesis and antiviral activity of new pyrazole and
[12] G.H. Al-Ansary, M.A. Ismail, D.A. Abou El Ella, S. Eid, K.A. Abouzid, Molecular
design and synthesis of HCV inhibitors based on thiazolone scaffold, Eur. J.
[13] J. Das, P. Chen, D. Norris, R. Padmanabha, J. Lin, R.V. Moquin, Z. Shen, L.S. Cook,
A.M. Doweyko, S. Pitt, S. Pang, D.R. Shen, et al., 2-Aminothiazole as a novel
kinase inhibitor template. Structure activity relationship studies toward the
[31] M.H. Khan, T. Akhtar, K.A. Yasin, N.A. Al-Masoudi, P.G. Jones, S. Hameed,
Synthesis, crystal structure and antiproliferative activity of 6-adamantyl-3-
aryl[1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles, Z. Naturforschung 65b (2010)
[32] M.H. Khan, T. Akhtar, N.A. Al-Masoudi, H. Stoeckli-Evans, S. Hameed, Syn-
thesis, crystal structure and anti-HIV activity of 2-adamantyl/ada-
mantylmethyl-5-aryl-1,3,4-oxadiazoles, Med. Chem.
8 (2012) 1190e1197,
[33] M.H. Khan, S. Hameed, M. Farman, N.A. Al-Masoudi, H. Stoeckli-Evans, Syn-
thesis, anti HIV and molecular modeling study of 3-aryl-6-adamantyl-methyl-
[1,2,4]triazolo[3,4-b]thiazdiazole derivatives, Z. Naturforschung 70b (2015)
[34] M. Zahid, K.A. Yasin, T. Akhtar, N.H. Rama, S. Hameed, N.A. Al-Masoudi,
R. Loddo, P. La Colla, New 2-(4-aryl)-5-(2-adamantylthiazol-4-yl)-1,3,4-
oxadiazoles as potential antiproliferative and antiviral agents, Arkivoc xi
[35] T. Akhtar, S. Hameed, N.A. Al-Masoudi, R. Loddo, P. La Colla, In vitro antitumor
and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione
discovery
of
N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-
piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide
(Dasatinib, BMS-354825) as a potent pan-Src kinase inhibitor, J. Med. Chem.
[14] D.J. Kempf, H.L. Sham, K.C. Marsh, C.A. Flentge, D. Betebenner, B.E. Green,
E. McDonald, S. Vasavanonda, A. Saldivar, N.E. Wideburg, W.M. Kati, L. Ruiz, et
al., Discovery of ritonavir, a potent inhibitor of HIV protease with high oral
bioavailability and clinical efficacy, J. Med. Chem. 41 (1998) 602e617, https://
[36] C. Pannecouque, D. Daelemans, E. De Clercq, Tetrazolium-based colorimetric
assay for the detection of HIV replication inhibitors: revisited, 20 years later,
[37] M. Popovic, M.G. Sarngadharan, E. Read, R.C. Gallo, Detection, isolation, and
continuous production of cytopathic retroviruses (HTLV-III) from patients
[16] Ø. Rist, M. Grimstrup, J.-M. Receveur, T.M. Frimurer, T. Ulven, E. Kontenis,
€
T. Hogberg, Novel selective thiazoleacetic acids as CRTH2 antagonists devel-
oped from in silico derived hits. Part 1, Bioorg. Med. Chem. Lett. 20 (2010)
ꢀ
[38] F. Barre-Sinoussi, J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest,
C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum,
L. Montagnier, Isolation of a T-lymphotropic retrovirus from a patient at risk
for acquired immune deficiency syndrome (AIDS), Science 220 (1983)
[17] Z. Xu, M. Ba, H. Zhou, Y. Cao, C. Tang, Y. Yang, R. He, Y. Liang, X. Zhang, Z. Li,
L. Zhu, Y. Guo, C. Guo, 2,4,5-Trisubstituted thiazole derivatives: a novel and
potent class of non-nucleoside inhibitors of wild type and mutant HIV-1
[18] M. Zia, T. Akhtar, S. Hameed, N.A. Al-Masoudi, New aryl-1,3-thiazole-4-
carbohydr-azides, their 1,3,4-oxadiazole-2-thione-1,2,4-triazole, isatin-3-
ylidene and carboxamide derivatives: synthesis and anti-HIV activity,
ꢀ
[40] U.C. Kassehin, F.A. Gbaguidi, C.N. Kapanda, C.R. McCurdy, J.H. Poupaert, Sol-
vent effect and catalysis in the synthesis of thiosemicarbazone derivatives
from ketones and 4’-phenylthiosemicarbazide, Afr. J. Pure Appl. Chem. 8
[19] K. Mahmood-ul-Hassan, S. Hameed, A. Tashfeen, N.A. Al-Masoudi, Synthesis,
crystal structure, anti-HIV, and antiproliferative activity of new oxadiazole
[20] S.M. Gomha, M.G. Badrey, M.M. Abdalla, R.K. Arafa, Novel anti-HIV-1 NNRTIs
based on a pyrazolo[4,3-d]isoxazole backbone scaffold: design, synthesis and
insights into the molecular basis of action, Med. MedChemCommun. 5 (2014)
[21] K.M. Dawood, T.M. Eldebss, H.S. El-Zahabi, M.H. Yousef, P. Metz, Synthesis of
some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer
[41] K.D. Hargrave, J.R. Proudfoot, K.G. Grozinger, E. Cullen, S.R. Kapadia, U.R. Patel,
V.U. Fuchs, S.C. Mauldin, J. Vitous, M.L. Behnke, J.M. Klunder, K. Pal, J.W. Skiles,
D.W. McNeil, J.M. Rose, G.C. Chow, et al., Novel nonnucleoside inhibitors of
HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyr-
[42] H. Mitsuya, K.J. Weinhold, P.A. Furman, M.H. St Clair, S.N. Lehrmann, R. Gallo,
30-Azido-30-deoxythymidine (BW A509U), an antiviral agent that inihibits the
ineffectivity and cytopathic effect of human T-lymphotropic virus type III/
lymphadenopathy associates virus in vitro, Proc. Natl. Acad. Sci. U.S.A. 82
[43] O.J. D'Cruz, F.M. Uckun, Dawn of non-nucleoside inhibitor-based anti-HIV
[44] O.J. D'Cruz, F.M. Uckun, Discovery of 2,5-dimethoxy-substituted 5-
bromopyridyl thiourea (PHI-236) as a potent broad-spectrum anti-human
immunodeficiency virus microbicide, Mol. Hum. Reprod. 11 (2005) 767e777,
ꢀ
ꢀ
ꢀ
[22] M. Popsavin, L. Torovic, M. Svircev, V. Kojic, G. Bogdanovic, V. Popsavin,
Synthesis and antiproliferative activity of two new tiazofurin analogues with
2'-amido functionalities, Bioorg. Med. Chem. Lett 16 (2006) 2773e2776,
[23] K.J. Wilson, C.R. Illig, N. Subasinghe, J.B. Hoffman, M.J. Rudolf, R. Soll, C. Molloy,
R. Bone, D. Green, T. Randall, M. Zhang, F.A. Lewandowski, et al., Synthesis of
thiophene-2-carboxamidines containing 2-aminothiazoles and their biolog-
ical evaluation as urokinase inhibitors, Bioorg. Med. Chem. Lett 11 (2001)
[24] C.M. Dario, C.G. Gian, M. Nova, F. Viviana US patent 0, 284,017 (1988).
[25] T.N. Minh An, M. A Kumar, S.H. Chang, M.Y. Kim, J.-A. Kim, K.D. Lee, Synthesis,
anticancer and antioxidant activity of novel 2,4-disubstituted thiazoles, Bull.
[45] E.A. Sudbeck, J.D. Jennissen, T.K. Venkatachalam, F.M. Uckun, Inhibitor of HIV-
1 reverse transcriptase: N'-(5-bromo-2-pyridyl)-N-[2-(2,5-dimethoxyphenyl)
€
[46] A.S. Cantrell, P. Engelhardt, M. Hogberg, S.R. Jaskunas, N.G. Johansson,
€
C.L. Jordan, J. Kangasmetsa, M.D. Kinnick, P. Lind, J.M. Morin, M.A. Muesing,
€
ꢀ
R. Noreen, B. Oberg, P. Pranc, C. Sahlberg, R.J. Ternansky, R.T. Vasileff, L. Vrang,
S.J. West, H. Zang, Phenethylthiazolyl thiourea (PETT) compounds as a new
class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further
[26] R.D. Kamble, R.J. Meshram, S.V. Hese, R.A. More, S.S. Kamble, R.N. Gacche,